FindTrial
Sign In

Screening and Validation of Autophagy Related Gene PEA15 as a Prognostic Biomarker in Early Endometrial Carcinoma

Screening and Validation of Autophagy Related Gene PEA15 as a Prognostic Biomarker in Early Endometrial Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101195
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage (FIGO stage I-II) endometrial cancer

Interventions

High expression of PEA15:None
Control group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients who underwent radical surgery for early-stage endometrial cancer at the Department of Obstetrics and Gynecology of Tongji Hospital Affiliated to Huazhong University of Science and Technology; 2.The postoperative pathological examination confirmed it as endometrial carcinoma (FIGO stage I and II).

Exclusion criteria

Exclusion criteria: 1.Advanced cases (FIGO stage III-IV); 2.Previous history of other malignant tumors; 3.Received neoadjuvant therapy before the operation,(chemotherapy/radiotherapy/hormone therapy, etc.); 4.Combine with severe underlying diseases (resulting in death);

Design outcomes

Primary

MeasureTime frame
Death or recurrence;—

Countries

China

Contacts

Public ContactLiqiong Cai

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

1732573196@qq.com+86 13871085465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026